NDC 49288-0119
Crab
Crab
Crab is a Intradermal; Subcutaneous Injection, Solution in the Non-standardized Allergenic category. It is labeled and distributed by Antigen Laboratories, Inc.. The primary component is Opilio Crab.
| Product ID | 49288-0119_28463a0e-70af-4169-b592-df65f4f13a5f |
| NDC | 49288-0119 |
| Product Type | Non-standardized Allergenic |
| Proprietary Name | Crab |
| Generic Name | Crab |
| Dosage Form | Injection, Solution |
| Route of Administration | INTRADERMAL; SUBCUTANEOUS |
| Marketing Start Date | 2011-07-22 |
| Marketing Category | BLA / BLA |
| Application Number | BLA102223 |
| Labeler Name | Antigen Laboratories, Inc. |
| Substance Name | OPILIO CRAB |
| Active Ingredient Strength | 0 g/mL |
| NDC Exclude Flag | E |
| Listing Certified Through | 2017-12-31 |
Packaging
NDC 49288-0119-3
10 mL in 1 VIAL, MULTI-DOSE (49288-0119-3)
| Marketing Start Date | 2011-07-22 |
| NDC Exclude Flag | N |
| Sample Package? | N |
NDC SPL Data Element Entries
NDC 49288-0119-5 [49288011905]
Crab INJECTION, SOLUTION
| Marketing Category | BLA |
| Application Number | BLA102223 |
| Product Type | NON-STANDARDIZED ALLERGENIC |
| Marketing Start Date | 2011-07-22 |
| Inactivation Date | 2019-10-29 |
NDC 49288-0119-1 [49288011901]
Crab INJECTION, SOLUTION
| Marketing Category | BLA |
| Application Number | BLA102223 |
| Product Type | NON-STANDARDIZED ALLERGENIC |
| Marketing Start Date | 2011-07-22 |
| Inactivation Date | 2019-10-29 |
NDC 49288-0119-4 [49288011904]
Crab INJECTION, SOLUTION
| Marketing Category | BLA |
| Application Number | BLA102223 |
| Product Type | NON-STANDARDIZED ALLERGENIC |
| Marketing Start Date | 2011-07-22 |
| Inactivation Date | 2019-10-29 |
NDC 49288-0119-2 [49288011902]
Crab INJECTION, SOLUTION
| Marketing Category | BLA |
| Application Number | BLA102223 |
| Product Type | NON-STANDARDIZED ALLERGENIC |
| Marketing Start Date | 2011-07-22 |
| Inactivation Date | 2019-10-29 |
NDC 49288-0119-3 [49288011903]
Crab INJECTION, SOLUTION
| Marketing Category | BLA |
| Application Number | BLA102223 |
| Product Type | NON-STANDARDIZED ALLERGENIC |
| Marketing Start Date | 2011-07-22 |
| Inactivation Date | 2019-10-29 |
Drug Details
Active Ingredients
| Ingredient | Strength |
|---|---|
| OPILIO CRAB | .05 g/mL |
NDC Crossover Matching brand name "Crab" or generic name "Crab"
| NDC | Brand Name | Generic Name |
|---|---|---|
| 0268-6130 | CRAB | RED KING CRAB |
| 22840-5770 | Crab | Callinectes sapidus |
| 36987-1206 | Crab | Crab |
| 36987-1207 | Crab | Crab |
| 36987-1208 | Crab | Crab |
| 36987-1209 | Crab | Crab |
| 49288-0119 | Crab | Crab |
Trademark Results [Crab]
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
 CRAB 98283192 not registered Live/Pending |
CRAB International Corp 2023-11-23 |
 CRAB 88436145 5926020 Live/Registered |
CHESAPEAKE REGION ACCESSIBLE BOATING, INC. 2019-05-17 |
 CRAB 85743294 4342247 Live/Registered |
Special Services Group, LLC 2012-10-02 |
 CRAB 85067295 3933049 Live/Registered |
Innovation First, Inc. 2010-06-21 |
 CRAB 79185933 not registered Dead/Abandoned |
CRAB Clinical Informatics Ltd 2016-01-26 |
 CRAB 78937887 not registered Dead/Abandoned |
Dircom Inc. 2006-07-26 |
 CRAB 77540929 3586954 Live/Registered |
Cancer Research And Biostatistics 2008-08-06 |
 CRAB 77083518 not registered Dead/Abandoned |
Dircom Inc. 2007-01-16 |
 CRAB 76317782 2682765 Dead/Cancelled |
Cancer Research And Biostatistics 2001-09-26 |
 CRAB 76317781 2682764 Live/Registered |
Cancer Research And Biostatistics 2001-09-26 |
 CRAB 74131415 1737986 Dead/Cancelled |
ECOLMARE SPA 1991-01-18 |
 CRAB 73496686 1342027 Live/Registered |
Chantiers Du Nord et de la MediterraneeS.A. 1984-08-27 |
© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.